In the specialized field of molecular biology research, the SHP-2 activating peptide (specifically the IRS1_pY1172(dPEG8)pY1222 construct) serves as a vital tool for those investigating the complex conformational shifts of the SHP-2 phosphatase. My experience with these biochemical reagents has highlighted how specific phosphotyrosine-containing sequences are essential for modulating enzyme behavior in controlled experimental settings.
The Mechanism of SHP-2 Activation
The primary function of an SHP-2 activating peptide revolves around its ability to interact with the Src Homology 2 (SH2) domains of the SHP-2 enzyme. Research indicates that SHP-2 is naturally maintained in a closed, autoinhibited conformation. The binding of a peptide—specifically a bisphosphorylated variant—to the N-SH2 domain is the key trigger. They propose a mechanism of activation of SHP2 where this binding event induces a structural rearrangement, effectively releasing the catalytic site and promoting the enzyme's phosphatase activity.
When we consider how SHP2 is activated by pY-peptides binding to the SH2 domains, it becomes clear why the precision of the sequence is paramount. The phosphotyrosine couples peptide binding and SHP2 activation via an allosteric network. In my observations of these assays, the use of a bidentate peptide—which may contain both ITIM and ITSM motifs—often results in a more robust response than mono-phosphorylated alternatives, as it facilitates a more stable interaction.
Experimental Considerations and Handling
For those working with the SHP-2 activating peptide in the lab, proper handling is non-negotiable to maintain the integrity of the molecule. Based on standard protocols:
* Solubility: The peptide is typically soluble in DMSO, which is the preferred solvent for maintaining stock concentrations before dilution into aqueou Targeting Oncogenic Src Homology 2 Domain-Containing s assay buffers.
* Storage: To prevent degradation, it is critical that the SHP2 Activating Peptide (IRS1_pY1172(dPEG8)pY1222) is stored at -20°C.
* Specificity: While peptides are highly effective, it is important to note that certain structures, such as OP, activates SHP2 only weakly. This highlights the It has been shown that the bisphosphorylated insulin receptor substrate 1 (IRS-1) binds to the (N)-SH2 domain of SHP-2 (PTPN11) resulting in activation of the importance of selecting the correct sequence for your specific experimental goal, whether you are studying SHP-2 signaling pathways or evaluating potential modulators.
Contextual Signaling and Interactions
The role of SHP-2 extends far beyond simple catalysis. Activation of SHP-2 and its association with Gab1 is a well-documented event that facilitates downstream signaling cascades, such as the RAS/ERK and PI3K/AKT pathways. SHP-2 leads to sustained RAS activation by dephosphorylating the RAS-GTPase-activating protein binding site on Gab1. Furthermore, SHPS-1 may play a crucial role both in the recruitment of SHP-2 from the cytosol to the plasma membrane, further increasing its catalytic potential in the cellul It interacts with diverse molecules in the cell, and regulates key signaling events including RAS/ERK, PI3K/AKT, JAK/STAT and PD-1 pathways downstream of ar environment.
It is interesting to contrast this with inhibition studies. For instance, while we use peptides to study NSC-13030 is a SHP2 inhibitor with an IC50 value of 3.2 μM. NSC-13030 reduces the proliferation and viability of breast cancer cells. NSC-13030 is applicable to activating mechanisms, other molecules like NSC-13030 is a SHP2 inhibitor that functions with an IC50 of 3.2 μM. Distinguishing between these two modes of action—activating SHP2 vs. inhibiting it—is fundamental for anyone mapping out the complex protein-protein interaction networks involving this phosphatase SHP-2 Activating Peptide (IRS1_pY1172(dPEG8)pY1222) .
Final Thoughts on Research Utility
Whether you are investigating the structural determinants of the N-SH2 domain or the kinetics of activated SHP2, the use of high-quality, synthetic peptides remains the gold standard. By utilizing a standardized SHP2 activating peptide, researchers can reliably replicate the allosteric shifts required to study the enzyme's function with SHP-2 Activating Peptide (IRS1_pY1172(dPEG8)pY1222) out relying on endogenous, variable stimuli. SHP2 is activated by binding of a phosphopeptide to the N-SH2 domain of SHP2, Phosphatase SHP2 pathogenic mutations enhance activity by and mastering this interaction is the key to unlocking deeper insights into the regulation of this essential signaling protein.